Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Equity Ratio (2022 - 2025)

Historic Equity Ratio for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to 0.15.

  • Indivior Pharmaceuticals' Equity Ratio changed N/A to 0.15 in Q3 2025 from the same period last year, while for Sep 2025 it was 0.15, marking a year-over-year change of. This contributed to the annual value of 0.26 for FY2024, which is 14466.68% down from last year.
  • As of Q3 2025, Indivior Pharmaceuticals' Equity Ratio stood at 0.15.
  • Indivior Pharmaceuticals' Equity Ratio's 5-year high stood at 0.07 during Q2 2023, with a 5-year trough of 0.26 in Q4 2024.
  • Over the past 4 years, Indivior Pharmaceuticals' median Equity Ratio value was 0.13 (recorded in 2025), while the average stood at 0.1.
  • As far as peak fluctuations go, Indivior Pharmaceuticals' Equity Ratio tumbled by 14466.68% in 2024, and later plummeted by 311167.27% in 2025.
  • Indivior Pharmaceuticals' Equity Ratio (Quarter) stood at 0.03 in 2022, then tumbled by 463.04% to 0.1 in 2023, then tumbled by 144.67% to 0.26 in 2024, then soared by 42.91% to 0.15 in 2025.
  • Its Equity Ratio stands at 0.15 for Q3 2025, versus 0.18 for Q2 2025 and 0.21 for Q1 2025.